Statera Biopharma, Inc.

STAB

STABStatera Biopharma, Inc. US flag

Other OTC

0.00

USD

- -

7,142.00Market Cap

Income Statement (USD)

API Chat

	2019 Y	2020 Y	2021 Y
Sales/Revenue/Turnover	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -
- Cost of Revenue	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -
Gross Profit	- -	- -	- -
+ Other Operating Income	- -	- -	- -
- Operating Expenses	3	11	29
+ Selling, General & Admin	2	6	18
+ Research & Development	1	5	12
+ Other Operating Expense	- -	- -	-1
Operating Income (Loss)	-3	-11	-29
- Non-Operating (Income) Loss	- -	2	73
+ Interest Expense, Net	- -	1	- -
+ Interest Expense	- -	1	- -
- Interest Income	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	1	73
Pretax Income	-3	-13	-102
- Income Tax Expense (Benefit)	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -
Income (Loss) from Cont Ops	-3	-13	-102
- Net Extraordinary Losses (Gains)	- -	-1	- -
+ Discontinued Operations	- -	- -	- -
+ Extraord. & Accounting Changes	- -	-1	- -
Income (Loss) Incl. MI	-3	-12	-102
- Minority Interest	- -	- -	- -
Net Income, GAAP	-3	-12	-102
- Preferred Dividends	- -	- -	- -
- Other Adjustments	- -	- -	- -
Net Income Avail to Common, GAAP	-3	-12	-102
EBIT	-3	-11	-29
EBITDA	-3	-11	-29
EBITDA Margin (%)	- -	- -	- -
EBITA	-3	-11	-29
Gross Margin (%)	- -	- -	- -
Operating Margin (%)	- -	- -	- -
Profit Margin (%)	- -	- -	- -
Sales per Employee	- -	- -	- -
Dividend per Share	- -	- -	- -
Depreciation Expense	- -	- -	- -
Basic Weighted Avg Shares	26	26	35
Basic EPS, GAAP	-0.13	-0.47	-2.9
Basic EPS from Cont Ops	-0.13	-0.49	-2.9
Diluted Weighted Avg Shares	26	26	35
Diluted EPS, GAAP	-0.13	-0.47	-2.9
Diluted EPS from Cont Ops	-0.13	-0.49	-2.9

Balance Sheet (USD)

API Chat

	2019 Y	2020 Y	2021 Y
Total Current Assets	- -	1	4
+ Cash, Cash Equivalents & STI	- -	1	2
+ Cash & Cash Equivalents	- -	1	2
+ ST Investments	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -
+ Inventories	- -	- -	- -
+ Raw Materials	- -	- -	- -
+ Work In Process	- -	- -	- -
+ Finished Goods	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -
+ Other Inventory	- -	- -	- -
+ Other ST Assets	- -	- -	2
+ Misc ST Assets	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -
Total Noncurrent Assets	- -	- -	17
+ Property, Plant & Equip, Net	- -	- -	1
+ Property, Plant & Equip	- -	- -	1
- Accumulated Depreciation	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -
+ LT Investments	- -	- -	- -
+ LT Receivables	- -	- -	- -
+ Other LT Assets	- -	- -	16
+ Total Intangible Assets	- -	- -	11
+ Goodwill	- -	- -	9
+ Other Intangible Assets	- -	- -	2
+ LT Deferred Tax Assets	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -
+ Misc LT Assets	- -	- -	5
Total Assets	- -	1	21
+ Payables & Accruals	2	3	6
+ Accounts Payable	2	1	4
+ Accrued Taxes	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -
+ Other Payables & Accruals	- -	2	2
+ ST Debt	2	2	5
+ ST Borrowings	2	2	5
+ ST Finance Leases	- -	- -	- -
+ Other ST Liabilities	- -	- -	1
+ Deferred Revenue	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -
+ Misc ST Liabilities	- -	- -	- -
Total Current Liabilities	4	5	11
+ LT Debt	- -	- -	11
+ LT Borrowings	- -	- -	11
+ LT Finance Leases	- -	- -	1
+ Other LT Liabilities	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -
+ Pension Liabilities	- -	- -	- -
+ Deferred Revenue	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -
+ Misc LT Liabilities	- -	- -	- -
Total Noncurrent Liabilities	- -	- -	11
Total Liabilities	4	5	23
+ Preferred Equity and Hybrid Capital	- -	- -	- -
+ Share Capital & APIC	11	24	128
+ Common Stock	- -	- -	- -
+ Additional Paid in Capital	11	24	128
- Treasury Stock	- -	- -	- -
+ Retained Earnings	-16	-28	-129
+ Other Equity	- -	- -	- -
Equity Before Minority Interest	-4	-4	-2
+ Minority/Non Controlling Interest	- -	- -	- -
Total Equity	-4	-4	-2
Total Liabilities & Equity	- -	1	21
Shares Outstanding	26	32	35
Number of Employees	- -	- -	- -
Capital Leases - Total	- -	- -	1
Net Debt	2	1	13
Net Debt to Equity	-42.82	-35.79	-886.35
Tangible Common Equity Ratio	-255,143.03	-353.05	-119.7
Current Ratio	- -	0.2	0.37
Cash Conversion Cycle	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2019 Y	2020 Y	2021 Y
+ Net Income	-3	-12	-102
+ Depreciation & Amortization	- -	- -	- -
+ Non-Cash Items	2	7	72
+ Stock-Based Compensation	- -	3	6
+ Deferred Income Taxes	- -	- -	- -
+ Asset Impairment Charge	- -	- -	68
+ Other Non-Cash Adj	2	4	-1
+ Chg in Non-Cash Work Cap	1	- -	1
+ (Inc) Dec in Accts Receiv	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	-1
+ Inc (Dec) in Accts Payable	1	- -	1
+ Inc (Dec) in Other	- -	- -	1
+ Net Cash From Disc Ops	- -	- -	- -
Cash from Operating Activities	- -	-5	-28
+ Change in Fixed & Intang	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	1	7
+ Increase in Capital Stock	- -	1	7
+ Decrease in Capital Stock	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	14
+ Cash from Divestitures	- -	- -	14
+ Cash for Acq of Subs	- -	- -	- -
+ Cash for JVs	- -	- -	- -
+ Other Investing Activities	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -
Cash from Investing Activities	- -	- -	13
+ Dividends Paid	- -	- -	- -
+ Net Cash From Debt	- -	- -	14
+ Cash From Debt	- -	- -	15
+ Repayments of Debt	- -	- -	-1
+ Other Financing Activities	- -	4	- -
+ Net Cash From Disc Ops	- -	- -	- -
Cash from Financing Activities	- -	6	21
Effect of Foreign Exchange Rates	- -	- -	- -
Net Changes in Cash	- -	1	6
EBITDA	-3	-11	-29
EBITDA Margin (%)	- -	- -	- -
Free Cash Flow	- -	-5	-28
Net Cash Paid for Acquisitions	- -	- -	-14
Free Cash Flow to Firm	- -	- -	- -
Free Cash Flow to Equity	- -	-5	-15
Free Cash Flow per Basic Share	-0.01	-0.2	-0.81
Price/Free Cash Flow	- -	- -	-2.88
Cash Flow to Net Income	0.07	0.42	0.28
Capital Expenditures	- -	- -	- -